209 related articles for article (PubMed ID: 32623700)
1. Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications.
Ma X; Yu J
Cell Oncol (Dordr); 2020 Oct; 43(5):751-761. PubMed ID: 32623700
[TBL] [Abstract][Full Text] [Related]
2. Bone Microenvironment and Osteosarcoma Metastasis.
Yang C; Tian Y; Zhao F; Chen Z; Su P; Li Y; Qian A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977425
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Bone Marrow-Resident Cells as a Microenvironment for Bone Metastasis.
Shiozawa Y
Adv Exp Med Biol; 2020; 1226():57-72. PubMed ID: 32030676
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
6. Bone Metastasis of Breast Cancer.
Tahara RK; Brewer TM; Theriault RL; Ueno NT
Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
[TBL] [Abstract][Full Text] [Related]
7. Dynamic modeling of bone metastasis, microenvironment and therapy: Integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy.
Coelho RM; Lemos JM; Alho I; Valério D; Ferreira AR; Costa L; Vinga S
J Theor Biol; 2016 Feb; 391():1-12. PubMed ID: 26657065
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.
De Castro J; García R; Garrido P; Isla D; Massuti B; Blanca B; Vázquez J
Clin Lung Cancer; 2015 Nov; 16(6):431-46. PubMed ID: 26264596
[TBL] [Abstract][Full Text] [Related]
9. Bone metastasis: Interaction between cancer cells and bone microenvironment.
Hiraga T
J Oral Biosci; 2019 Jun; 61(2):95-98. PubMed ID: 31109867
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.
Schmid-Alliana A; Schmid-Antomarchi H; Al-Sahlanee R; Lagadec P; Scimeca JC; Verron E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300334
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets.
Tamura T; Yoshioka Y; Sakamoto S; Ichikawa T; Ochiya T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932657
[TBL] [Abstract][Full Text] [Related]
12. Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases.
Sottnik JL; Dai J; Zhang H; Campbell B; Keller ET
Cancer Res; 2015 Jun; 75(11):2151-8. PubMed ID: 25855383
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the role of bone marrow stromal cells on bone metastases.
Buenrostro D; Park SI; Sterling JA
Biomed Res Int; 2014; 2014():875305. PubMed ID: 25054153
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and bone metastasis: a new challenge.
Croset M; Santini D; Iuliani M; Fioramonti M; Zoccoli A; Vincenzi B; Tonini G; Pantano F
Molecules; 2014 Jul; 19(7):10115-28. PubMed ID: 25019555
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches to target the microenvironment of bone metastasis.
Hofbauer LC; Bozec A; Rauner M; Jakob F; Perner S; Pantel K
Nat Rev Clin Oncol; 2021 Aug; 18(8):488-505. PubMed ID: 33875860
[TBL] [Abstract][Full Text] [Related]
16. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
Whang YM; Jung SP; Kim MK; Chang IH; Park SI
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapies in bone metastasis.
Clément-Demange L; Clézardin P
Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
[TBL] [Abstract][Full Text] [Related]
19. Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.
Chappard D; Bouvard B; Baslé MF; Legrand E; Audran M
Morphologie; 2011 Jun; 95(309):65-75. PubMed ID: 21620753
[TBL] [Abstract][Full Text] [Related]
20. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
Hiraga T
Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
